TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-14.07%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.34B
AUM Growth
+$2.34B
(-15%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
40.93%
Holding
221
New
9
Increased
52
Reduced
52
Closed
18
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$14.9M |
| 2 |
Medtronic
MDT
|
$12.9M |
| 3 |
UnitedHealth
UNH
|
$7.69M |
| 4 |
Pfizer
PFE
|
$7.1M |
| 5 |
Merck
MRK
|
$7.1M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$17M |
| 2 |
AstraZeneca
AZN
|
$11M |
| 3 |
Idexx Laboratories
IDXX
|
$9.46M |
| 4 |
Omega Healthcare
OHI
|
$7.02M |
| 5 |
Viatris
VTRS
|
$6.94M |
Sector Composition
| 1 | Healthcare | 94.39% |
| 2 | Real Estate | 2.48% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
HCA Healthcare
HCA
$94.5B
| $9.25M | 0.4% | 74,335 | – | – |
|
52
Alnylam Pharmaceuticals
ALNY
$58.5B
| $9.2M | 0.39% | 126,176 | – | – |
|
53
Galapagos
GLPG
$2.07B
| $9.16M | 0.39% | 99,815 | – | – |
|
54
Sabra Healthcare REIT
SBRA
$4.58B
| $8.95M | 0.38% | 542,862 -181,744 | -25% | -$3M |
|
|
AMRN
55
Amarin Corp
AMRN
$311M
| $8.9M | 0.38% | 654,052 -99,997 | -13% | -$1.36M |
|
56
Edwards Lifesciences
EW
$47.8B
| $8.7M | 0.37% | 56,798 -19,898 | -26% | -$3.05M |
|
57
McKesson
MCK
$85.4B
| $8.7M | 0.37% | 78,720 -4,227 | -5% | -$467K |
|
58
Amicus Therapeutics
FOLD
$2.34B
| $8.39M | 0.36% | 875,304 | – | – |
|
59
GSK
GSK
$79.9B
| $8.36M | 0.36% | 218,700 | – | – |
|
60
Cencora
COR
$56.5B
| $8.32M | 0.36% | 111,807 | – | – |
|
|
MDCO
61
DELISTED
Medicines Co
MDCO
| $8.21M | 0.35% | 428,992 +263,151 | +159% | +$5.04M |
|
62
Sanofi
SNY
$121B
| $7.81M | 0.33% | 179,900 | – | – |
|
|
LTC
63
LTC Properties
LTC
$1.68B
| $7.45M | 0.32% | 178,623 -31,050 | -15% | -$1.29M |
|
|
XLRN
64
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.44M | 0.32% | 170,766 | – | – |
|
65
Smith & Nephew
SNN
$16.3B
| $6.93M | 0.3% | 185,478 | – | – |
|
|
DPLO
66
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $6.81M | 0.29% | 505,701 +66,700 | +15% | +$898K |
|
|
BPMC
67
DELISTED
Blueprint Medicines
BPMC
| $6.75M | 0.29% | 125,207 -20,794 | -14% | -$1.12M |
|
68
Exelixis
EXEL
$10.1B
| $6.68M | 0.29% | 339,435 -214,505 | -39% | -$4.22M |
|
69
ResMed
RMD
$40.2B
| $6.68M | 0.29% | 58,630 | – | – |
|
70
Medical Properties Trust
MPW
$2.7B
| $6.65M | 0.28% | 413,809 -63,600 | -13% | -$1.02M |
|
71
Esperion Therapeutics
ESPR
$448M
| $6.55M | 0.28% | 142,289 -46,998 | -25% | -$2.16M |
|
|
PRAH
72
DELISTED
PRA Health Sciences, Inc.
PRAH
| $6.48M | 0.28% | 70,460 +38,000 | +117% | +$3.49M |
|
|
SHPG
73
DELISTED
Shire pic
SHPG
| $6.3M | 0.27% | 36,216 | – | – |
|
|
DOC
74
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.27M | 0.27% | 391,016 | – | – |
|
75
Align Technology
ALGN
$10.3B
| $6.25M | 0.27% | 29,860 +18,616 | +166% | +$3.9M |
|